Tightly regulated induction of the adhesion molecule Necl-5/CD155 during rat liver regeneration and acute liver injury

Hepatology

Volumn 43, Issue 2, 2006, Pages 325-334

  Erickson, Briana M ^a   Thompson, Nancy L ^b   Hixson, Douglas C ^a,b,c  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON TETRACHLORIDE; CELL ADHESION MOLECULE; PROTEIN NECTIN LIKE MOLECULE 5; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; GENE EXPRESSION; LIVER CELL; LIVER INJURY; LIVER REGENERATION; LIVER RESECTION; MALE; NONHUMAN; NORTHERN BLOTTING; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION;

ANIMALS; BLOTTING, NORTHERN; CARBON TETRACHLORIDE POISONING; CELL ADHESION MOLECULES; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; GLYCOPROTEINS; HEPATECTOMY; LIVER; LIVER REGENERATION; MALE; MEMBRANE PROTEINS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-MYC; RATS; RATS, INBRED F344; RECEPTORS, VIRUS;

EID: 33644543793     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21021     Document Type: Article

References (50)

1. Mendelsohn CL, Wimmer E, Racaniello VR. Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 1989;56:855-865.
2. Ravens I, Seth S, Forster R, Bernhardt G. Characterization and identification of Tage4 as the murine orthologue of human poliovirus receptor/CD155. Biochem Biophys Res Commun 2003;312:1364-1371.
3. Hixson DC, McEntire K, Chesner J, Faris R, Weltman J, Marceau N. Monoclonal antibody (MAb) recognizing a glycoprotein absent from normal tissues but present on transplantable (THC) and primary (PHC) hepatocellular carcinomas induced by azo dye. Proceedings of AACR 1986;27:365.
4. Faris RA, McEntire KD, Thompson NL, Hixson DC. Identification and characterization of a rat hepatic oncofetal membrane glycoprotein. Cancer Res 1990;50:4755-4763.
5. Lim YP, Fowler LC, Hixson DC, Wehbe T, Thompson NL. TuAg.1 is the liver isoform of the rat colon tumor-associated antigen pE4 and a member of the immunoglobulin-like supergene family. Cancer Res 1996;56:3934-3940.
6. Douillard JY, Laborda J, Burg C, Ridge J, Levenbook I, Blottiere H, et al. Monoclonal antibodies to a rat colon carcinoma: model for monoclonal antibody therapy of solid tumors. Cancer Res 1989;49:687-692.
7. Chadeneau C, Denis MG, Blottiere HM, Gregoire M, Douillard JY, Meflah K. Characterization, isolation and amino terminal sequencing of a rat colon carcinoma-associated antigen. Int J Cancer 1991;47:903-908.
8. Takai Y, Irie K, Shimizu K, Sakisaka T, Ikeda W. Nectins and nectin-like molecules: roles in cell adhesion, migration, and polarization. Cancer Sci 2003;94:655-667.
9. Takahashi K, Nakanishi H, Miyahara M, Mandai K, Satoh K, Satoh A, et al. Nectin/PRR: an immunoglobulin-like cell adhesion molecule recruited to cadherin-based adherens junctions through interaction with Afadin, a PDZ domain-containing protein. J Cell Biol 1999;145:539-549.
10. Takai Y, Nakanishi H. Nectin and afadin: novel organizers of intercellular junctions. J Cell Sci 2003;116:17-27.
11. Honda T, Shimizu K, Fukuhara A, Irie K, Takai Y. Regulation by nectin of the velocity of the formation of adherens junctions and tight junctions. Biochem Biophys Res Commun 2003;306:104-109.
12. Honda T, Shimizu K, Kawakatsu T, Yasumi M, Shingai T, Fukuhara A, et al. Antagonistic and agonistic effects of an extracellular fragment of nectin on formation of E-cadherin-based cell-cell adhesion. Genes Cells 2003;8:51-63.
13. Mueller S, Wimmer E. Recruitment of nectin-3 to cell-cell junctions through trans-heterophilic interaction with CD155, a vitronectin and poliovirus receptor that localizes to alpha(v)beta3 integrin-containing membrane microdomains. J Biol Chem 2003;278:31251-31260.
14. Ikeda W, Kakunaga S, Itoh S, Shingai T, Takekuni K, Satoh K, et al. Tage4/Nectin-like molecule-5 heterophilically trans-interacts with cell adhesion molecule Nectin-3 and enhances cell migration. J Biol Chem 2003;278:28167- 28172.
15. Lange R, Peng X, Wimmer E, Lipp M, Bernhardt G. The poliovirus receptor CD155 mediates cell-to-matrix contacts by specifically binding to vitronectin. Virology 2001;285:218-227.
16. Ikeda W, Kakunaga S, Takekuni K, Shingai T, Satoh K, Morimoto K, et al. Nectin-like molecule-5/Tage4 enhances cell migration in an integrin-dependent, nectin-3-independent manner. J Biol Chem 2004;279:18015-18025.
17. Sato T, Irie K, Ooshio T, Ikeda W, Takai Y. Involvement of heterophilic trans-interaction of Necl-5/Tage4/PVR/CD155 with nectin-3 in formation of nectin- and cadherin-based adherens junctions. Genes Cells 2004;9:791-799.
18. Kakunaga S, Ikeda W, Shingai T, Fujito T, Yamada A, Minami Y, et al. Enhancement of serum- and platelet-derived growth factor-induced cell proliferation by Necl-5/Tage4/poliovirus receptor/CD155 through the Ras-Raf-MEK-ERK signaling. J Biol Chem 2004;279:36419-36425.
19. Iwasaki A, Welker R, Mueller S, Linehan M, Nomoto A, Wimmer E. Immunofluorescence analysis of poliovirus receptor expression in Peyer's patches of humans, primates, and CD155 transgenic mice: implications for poliovirus infection. J Infect Dis 2002;186:585-592.
20. Freistadt M. Distribution of the poliovirus receptor in human tissue. In: Wimmer E, ed. Cellular Receptors for Animal Viruses. Plainview, NY: Cold Spring Harbor Laboratory Press, 1994:445-461.
21. Koike S, Horie H, Ise I, Okitsu A, Yoshida M, Iizuka N, et al. The poliovirus receptor protein is produced both as membrane-bound and secreted forms. EMBO J 1990;9:3217-3224.
22. Chadeneau C, LeCabellec M, LeMoullac B, Meflah K, Denis MG. Overexpression of a novel member of the immunoglobulin superfamily in Min mouse intestinal adenomas. Int J Cancer 1996;68:817-821.
23. Freistadt MS, Fleit HB, Wimmer E. Poliovirus receptor on human blood cells: a possible extraneural site of poliovirus replication. Virology 1993;195:798-803.
24. Solecki D, Schwarz S, Wimmer E, Lipp M, Bernhardt G. The promoters for human and monkey poliovirus receptors. Requirements for basic and cell type-specific activity. J Biol Chem 1997;272:5579-5586.
25. Pende D, Bottino C, Castriconi R, Cantoni C, Marcenaro S, Rivera P, et al. PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis. Mol Immunol 2005;42:463-469.
26. Chadeneau C, LeMoullac B, Denis MG. A novel member of the immunoglobulin gene superfamily expressed in rat carcinoma cell lines. J Biol Chem 1994;269:15601-15605.
27. Masson D, Jarry A, Baury B, Blanchardie P, Laboisse C, Lustenberger P, et al. Overexpression of the CD155 gene in human colorectal carcinoma. Gut 2001;49:236-240.
28. Gromeier M, Lachmann S, Rosenfeld MR, Gutin PH, Wimmer E. Intergeneric poliovirus recombinants for the treatment of malignant glioma. Proc Natl Acad Sci U S A 2000;97:6803-6808.
29. Higgins GM, Anderson RM. Experimental pathology of the liver I: restoration of the liver of the white rat following surgical removal. Arch Pathol 1931;12:186-202.
30. Tsao MS, Smith JD, Nelson KG, Grisham JW. A diploid epithelial cell line from normal adult rat liver with phenotypic properties of 'oval' cells. Exp Cell Res 1984;154:38-52.
31. Coleman WB, Wennerberg AE, Smith GJ, Grisham JW. Regulation of the differentiation of diploid and some aneuploid rat liver epithelial (stemlike) cells by the hepatic microenvironment. Am J Pathol 1993;142:1373-1382.
32. Rozen S, Skaletsky HJ. Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S, Misener S, eds. Bioinformatics Methods and Protocols: Methods in Molecular Biology. Totowa, NJ: Humana Press, 2000:365-386.
33. Depreter M, Vandesompele J, Espeel M, Speleman F, Roels F. Modulation of the peroxisomal gene expression pattern by dehydroepiandrosterone and vitamin D: therapeutic implications. J Endocrinol 2002;175:779-792.
34. Hixson DC, Allison JP, Chesner JE, Leger MJ, Ridge LL, Walborg EF Jr. Characterization of a Family of glycoproteins associated with the bile canalicular membrane of normal hepatocytes but not expressed by two transplantable rat hepatocellular carcinomas. Cancer Res 1983;43:3874-3884.
35. Hixson DC, Chapman L, McBride A, Faris R, Yang L. Antigenic phenotypes common to rat oval cells, primary hepatocellular carcinomas and developing bile ducts. Carcinogenesis 1997;18:1169-1175.
36. Hixson DC, Brown J, McBride AC, Affigne S. Differentiation status of rat ductal cells and ethionine-induced hepatic carcinomas defined with surface-reactive monoclonal antibodies. Exp Mol Pathol 2000;68:152-169.
37. Taub R. Expression and function of growth-induced genes during liver regeneration. In: Jirtle RL, ed. Liver Regeneration and Carcinogenesis. San Diego, CA: Academic Press, 1995:71-97.
38. Fausto N, Campbell JS. The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech Dev 2003;120:117-130.
39. Sell S, Ilic Z: Response to injury. In: Liver Stem Cells. Austin, TX: R.G. Landes Company, 1997:223-286.
40. Taub R. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol 2004;5:836-847.
41. Hixson DC. Animal models for assessing the contribution of stem cells to liver development. In: Sell S, ed. Stem Cells Handbook. Totowa, NJ: Humana Press Inc., 2004:353-366.
42. Dunsford HA, Karnasuta C, Hunt JM, Sell S. Different lineages of chemically induced hepatocellular carcinoma in rats defined by monoclonal antibodies. Cancer Res 1989;49:4894-4900.
43. Burt AD, Robertson JL, Heir J, MacSween RN. Desmin-containing stellate cells in rat liver: distribution in normal animals and response to experimental acute liver injury. J Pathol 1986;150:29-35.
44. Fujito T, Ikeda W, Kakunaga S, Minami Y, Kajita M, Sakamoto Y, et al. Inhibition of cell movement and proliferation by cell-cell contact-induced interaction of Necl-5 with nectin-3. J Cell Biol 2005;171:165-173.
45. Coleman WB, McCullough KD, Esch GL, Faris RA, Hixson DC, Smith GJ, et al. Evaluation of the differentiation potential of WB-F344 rat liver epithelial stem-like cells in vivo: differentiation to hepatocytes after transplantation into dipeptidylpeptidase-IV-deficient rat liver. Am J Pathol 1997;151:353-359.
46. Oda T, Ohka S, Nomoto A. Ligand stimulation of CD155alpha inhibits cell adhesion and enhances cell migration in fibroblasts. Biochem Biophys Res Commun 2004;319:1253-1264.
47. Sloan KE, Eustace BK, Stewart JK, Zehetmeier C, Torella C, Simeone M, et al. CD155/PVR plays a key role in cell motility during tumor cell invasion and migration. BMC Cancer 2004;4:73.
48. Bottino C, Castriconi R, Pende D, Rivera P, Nanni M, Carnemolla B, et al. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J Exp Med 2003;198:557-567.
49. Fuchs A, Cella M, Giurisato E, Shaw AS, Colonna M. Cutting edge: CD96 (tactile) promotes NK cell-target cell adhesion by interacting with the poliovirus receptor (CD155). J Immunol 2004;172:3994-3998.
50. Nakatani K, Kaneda K, Seki S, Nakajima Y. Pit cells as liver-associated natural killer cells: morphology and function. Med Electron Microsc 2004;37:29-36.